Itaconix PLC
LSE:ITX
Itaconix PLC
Itaconix Plc engages in designing, developing, and formulating novel polymers to improve the performance of existing consumer products. The company is headquartered in Deeside, Flintshire/Sir Fflint and currently employs 11 full-time employees. The company went IPO on 2012-07-10. The firm's bio-based specialty polymers is focused on improving the safety, performance and sustainability of consumer and industrial products. Itaconix has established a range of polymer ingredients for application in cleaning and hygiene, energy and industry, surface coatings and agriculture. The firm's products are categorized into two markets: homecare and industrial, and personal care. Its homecare and industrial products include Itaconix TSI 322, Itaconix DSP 2K, Itaconix CHT 122, Itaconix Zinador 22L, Itaconix Zinador 35L and Itaconix Velasoft. The firm's personal care products include Itaconix Velafresh ZP20, Itaconix Velafresh ZP30 and Itaconix Amaze SP.
Itaconix Plc engages in designing, developing, and formulating novel polymers to improve the performance of existing consumer products. The company is headquartered in Deeside, Flintshire/Sir Fflint and currently employs 11 full-time employees. The company went IPO on 2012-07-10. The firm's bio-based specialty polymers is focused on improving the safety, performance and sustainability of consumer and industrial products. Itaconix has established a range of polymer ingredients for application in cleaning and hygiene, energy and industry, surface coatings and agriculture. The firm's products are categorized into two markets: homecare and industrial, and personal care. Its homecare and industrial products include Itaconix TSI 322, Itaconix DSP 2K, Itaconix CHT 122, Itaconix Zinador 22L, Itaconix Zinador 35L and Itaconix Velasoft. The firm's personal care products include Itaconix Velafresh ZP20, Itaconix Velafresh ZP30 and Itaconix Amaze SP.
Record Revenue: Itaconix delivered record H1 2025 sales of $4.8 million, up 73% from H1 2024, and up 20% from its previous half-year record.
Gross Profit Growth: Gross profit reached $1.7 million, maintaining a 35% margin and up by $600,000 from the prior year.
Improved EBITDA: Adjusted EBITDA loss narrowed to $200,000 from $800,000 in H1 2024, showing significant progress toward breakeven.
Strong Cash Position: The company ended the period with $6.6 million in net working capital, confident it has resources to reach profitability.
North America Leads: 68% of sales came from North America, with major growth driven by the detergent sector and SPARX program.
SPARX Program Expansion: SPARX formulation solutions revenue rose 156% to $1.5 million, with 10 new products expected in market by year-end.
Outlook Positive: Management remains optimistic for 2025 and 2026, targeting profitability and expansion into new product lines and geographies.
